Panacea Biotec Ltd (PANACEABIO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Panacea Biotec Ltd (PANACEABIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10148
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Panacea Biotec Ltd (Panacea) is a research-based health management company which focuses on manufactures and commercializes pharmaceuticals; biopharmaceuticals; natural, and indigenous products; and vaccines. Its vaccines portfolio includes paediatric vaccines, including trivalent and monovalent oral polio vaccine, and Enivac HB vaccine; and combinative vaccines, including Easyfive-TT (DTwP-HepB-Hib), Novohib (haemophilus typeb conjugate vaccine IP) and Polprotec (inactivated poliomyelitis vaccine). Its pharmaceutical formulations span the therapeutic areas of oncology, nephrology, pain management, diabetes management, and organ transplantation. The company also offers contract research and manufacturing services. Panacea operates research and development centers and manufacturing facilities. It has subsidiaries in India, Switzerland and Germany. Panacea is headquartered in New Delhi, India.

Panacea Biotec Ltd (PANACEABIO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panacea Biotec Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Panacea Biotec Enters into Agreement with Natco Pharma and Breckenridge Pharma 11
Panacea Biotec Enters into Agreement with Serum Institute of India 12
Panacea Biotech Enters into Agreement with Bionpharma 13
Panacea Biotec Enters into Agreement with Pharma Company for Immunosuppressant Generic Product 14
Panacea Biotec Enters into Agreement with Rising Pharma 15
Panacea Biotec Enters Into R&D Agreement With Kremers Urban For Generic Drugs 16
Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 17
Licensing Agreements 18
Bionpharma Enters into Licensing Agreement with Panacea Biotech 18
Panacea Biotec Expands Licensing Agreement with Apotex 19
Equity Offering 20
Panacea Biotec Receives Board Approval for Public Offering of Shares to Raise USD41.5 Million 20
Acquisition 21
Panacea Biotec Plans to Sell Its Stake in NewRise Healthcare 21
Panacea Biotec Ltd – Key Competitors 22
Panacea Biotec Ltd – Key Employees 23
Panacea Biotec Ltd – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Joint Venture 25
Recent Developments 26
Legal and Regulatory 26
Mar 09, 2018: Panacea Biotec Announces Receipt of Establishment Inspection Report (EIR) from USFDA 26
Oct 17, 2017: Panacea Biotec receives Certificate of GMP Compliance with manufacturing authorizations for 22 medicinal products from State Service of Ukraine on Medicines and Drugs Control 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panacea Biotec Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panacea Biotec Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Panacea Biotec Enters into Agreement with Natco Pharma and Breckenridge Pharma 11
Panacea Biotec Enters into Agreement with Serum Institute of India 12
Panacea Biotech Enters into Agreement with Bionpharma 13
Panacea Biotec Enters into Agreement with Pharma Company for Immunosuppressant Generic Product 14
Panacea Biotec Enters into Agreement with Rising Pharma 15
Panacea Biotec Enters Into R&D Agreement With Kremers Urban For Generic Drugs 16
Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 17
Bionpharma Enters into Licensing Agreement with Panacea Biotech 18
Panacea Biotec Expands Licensing Agreement with Apotex 19
Panacea Biotec Receives Board Approval for Public Offering of Shares to Raise USD41.5 Million 20
Panacea Biotec Plans to Sell Its Stake in NewRise Healthcare 21
Panacea Biotec Ltd, Key Competitors 22
Panacea Biotec Ltd, Key Employees 23
Panacea Biotec Ltd, Other Locations 24
Panacea Biotec Ltd, Subsidiaries 24
Panacea Biotec Ltd, Joint Venture 25

List of Figures
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Panacea Biotec Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Panacea Biotec Ltd (PANACEABIO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bord na Mona Plc:企業の戦略的SWOT分析
    Bord na Mona Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Arrowhead Pharmaceuticals Inc (ARWR):製薬・医療:M&Aディール及び事業提携情報
    Summary Arrowhead Pharmaceuticals Inc (Arrowhead), formerly Arrowhead Research Corp, is a pharmaceutical company that develops and markets medicinal products. The company develops pipeline drugs that are being developed to treat chronic hepatitis B virus infection for the treatment of liver disease, …
  • Sims Metal Management Ltd:企業の戦略・SWOT・財務分析
    Sims Metal Management Ltd - Strategy, SWOT and Corporate Finance Report Summary Sims Metal Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Infinity Pharmaceuticals Inc (INFI)-製薬・医療分野:企業M&A・提携分析
    Summary Infinity Pharmaceuticals Inc (Infinity Pharmaceuticals) is a biopharmaceutical company, which discovers and develops medicines to people suffering with difficult-to-treat diseases. It focuses on small molecule drugs designed to address diseases in the areas of cancer and inflammation. The co …
  • Apollo Education Group, Inc.:企業の戦略・SWOT・財務分析
    Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • G4S plc:企業のM&A・事業提携・投資動向
    G4S plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's G4S plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • Pembina Pipeline Corp (PPL):企業の財務・戦略的SWOT分析
    Pembina Pipeline Corp (PPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Kopin Corp (KOPN):企業の財務・戦略的SWOT分析
    Summary Kopin Corp (Kopin) is a technology company that offers wearable technologies and solutions. The company’s products comprise wearable headsets, transmissive liquid crystal displays, batteries, ASIC products, module products, whisper voice chip among others. Kopin technologies and solutions he …
  • Orpea SA (ORP):企業の財務・戦略的SWOT分析
    Summary Orpea SA (Orpea) is a healthcare consulting company that offers clinical care services. The company provides services such as suite care clinic services, retirement homes, and mental hospital services, among others. Its mental hospital services include treatment of mood disorders, overuse sy …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):医療機器:M&Aディール及び事業提携情報
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Lietuvos energijos gamyba AB (LNR1L):企業の財務・戦略的SWOT分析
    Lietuvos energijos gamyba AB (LNR1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Aequus Pharmaceuticals Inc (AQS):企業の財務・戦略的SWOT分析
    Summary Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS304 finds application in the treatment of neurological disorders, and AQS303 is used for the treatment of treatment o …
  • Sun International Ltd:戦略・SWOT・企業財務分析
    Sun International Ltd - Strategy, SWOT and Corporate Finance Report Summary Sun International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Lucigen Corp:医療機器:M&Aディール及び事業提携情報
    Summary Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vector …
  • Bruker Corporation:企業の戦略・SWOT・財務情報
    Bruker Corporation - Strategy, SWOT and Corporate Finance Report Summary Bruker Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Portage la Prairie Mutual Insurance Company:企業の戦略的SWOT分析
    The Portage la Prairie Mutual Insurance Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Yomeishu Seizo Co Ltd (2540):企業の財務・戦略的SWOT分析
    Yomeishu Seizo Co Ltd (2540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Stresau Laboratory, Inc.:企業の戦略・SWOT・財務情報
    Stresau Laboratory, Inc. - Strategy, SWOT and Corporate Finance Report Summary Stresau Laboratory, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • 1414 Degrees Ltd (14D):企業の財務・戦略的SWOT分析
    1414 Degrees Ltd (14D) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆